Vaccine Market | Global Share, Trend Analysis Report

Vaccine Market Report, By Vaccine Type (Live Attenuated, Inactivated & Subunit, Conjugate, Toxoid and Recombinant Vaccines), Valance Type, Route of Administration, Indication Type, Patient Type, Distribution Channel and Geography - Global Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : hc2097 | Publish Date : Jan, 2020 | Industry : Healthcare | Geography : Global


Vaccines are one of the most successful and cost-effective public health tools for saving lives and preventing devastating illness, particularly among the children’s worldwide. Diseases that were once too common has now became rare predominantly due to prevalent immunization. Routine vaccination campaigns and programs by governments have prevented the deaths of hundreds of millions of people and has helped saved public health expenditures.

Increasing government focus on immunization programs, emerging new diseases and technological progress in vaccine administration has provoked research & development sector in industries to invent new and improved vaccine in future.

Vaccine Market Outlook

Developing focus on immunization programs, rising prevalence rate of infectious disease, increasing government support for vaccine development and growing use of adjuvants in vaccine are propelling the global vaccine market. However, high cost involved in manufacturing of vaccines is the major element responsible for drop in the vertical growth. Prolonged regulatory processes, delayed approval, stringent laws and market uncertainties are the major dynamics attributing to withdrawal of several drug manufacturing companies out of the vaccine vertical hampering innovation and development leading to shortage in vaccine supply.


Vaccine Market Segmental Overview

The global vaccine market is segmented based on vaccine type, valance type, route of administration, indication type, patient type, distribution channel and geography.

Vaccine Market by Vaccine Type

Different type of vaccines studied in this vertical are live attenuated, inactivated & subunit, conjugate, toxoid and recombinant vaccines. Live attenuated vaccines are derived from diseases causing pathogens such as virus or bacteria. These pathogens are weakened by decreasing their virulence properties under laboratory condition. 

Vaccine Market by Valance Type

Vaccines are categorized based upon their immunity against the number of pathogens such as monovalent and multivalent vaccines. Multivalent vaccines contain two or more strains of the same antigen whereas, monovalent consists of single strain from a single antigen.

Vaccine Market by Route of Administration Type

Vaccines are designed to administer orally, can be injected and also, administered through intranasal spray application. They are often injected intramuscularly, subcutaneously and intradermally. Vaccines such as BCG vaccine is given through intradermal route to avoid the risk of neurovascular injury. 

Vaccine Market by Indication Type

Vaccination is carried out for indications such as hepatitis, polio, varicella, diphtheria, pertussis, human papilloma virus, tetanus and influenza. Also, it is used against rotavirus, measles, mumps, and rubella, meningococcal & pneumococcal diseases.

Vaccine Market by Patient Type

Vaccinations are offered to pediatrics and adults. Traveler’s vaccines also called as travel immunization are given an individual before visiting certain areas of the world to avoid risk of getting serious illnesses.

Vaccine Market by Distribution Channel 

Globally, vaccines are distributed to institutional sales, hospital pharmacies, retail pharmacies and clinics. It is predominantly used in hospital when vaccination period is announced.

Vaccine Market by Geography

Global vaccine market is analyzed across the various regions geographically including North America, Europe, Asia Pacific and rest of world. In 2018, the North America held the dominant position in this industry, due to rising incidence of both viral and bacterial infectious diseases coupled with increasing research & developmental activities by key market players in the region. Moreover, Asia pacific is expected to grow rapidly during the projection period 2019 to 2020, due to increasing prevalence of infectious diseases in the region.

Global Vaccine Market Key Players

Pivotal market performers in the global vaccine market are AstraZeneca, GlaxoSmithKline plc, Sanofi Pasteur SA, Pfizer, Inc., Panacea Biotec, Merck & Co., Inc., Janssen Pharmaceutical Company (Part of Johnson & Johnson),Serum Institute of India Ltd, Emergent Bio Solutions Inc.,CSL, Bavarian Nordic, IBSS BIOMED S.A., Novavax AB, Mitsubishi Tanabe Pharma Corporation, Astellas Pharma, Biological E and  Daiichi Sankyo Company. Major players operating in this market are focusing on merging, acquisitions and new product launch as novel vaccines for the existing and emerging disease, to enhance the market share.

The global vaccine market is segmented by vaccine type, valance type, route of administration, indication type, patient type, distribution channel and geography. Different type of vaccines studied in this vertical are live attenuated, inactivated & subunit, conjugate, toxoid and recombinant vaccines. Vaccines are categorized based upon their immunity against the number of pathogens such as monovalent and multivalent vaccines. 

Vaccines are designed to administer orally, can be injected and also, administered through intranasal spray application. Vaccination is carried out for indications such as hepatitis, polio, varicella, diphtheria, pertussis, human papilloma virus, tetanus and influenza. Vaccinations are offered to pediatrics and adults. 

Globally, vaccines are distributed to institutional sales, hospital pharmacies, retail pharmacies and clinics. The vaccine market is analyzed across the various regions geographically including North America, Europe, Asia Pacific and rest of world. In 2018, the North America held the dominant position in this industry, due to rising incidence of both viral and bacterial infectious diseases coupled with increasing research & developmental activities by key market players in the region.


Why to buy this report:

  • The report offers changing market dynamics in the global vaccine market, presenting historical, current and projected market size in terms of value (USD million)
  • The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of global vaccine market
  • It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the global vaccine market performance
  • The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of global vaccine market